These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 19525731

  • 1. Exposure to topical apraclonidine in children with glaucoma.
    Wright TM, Freedman SF.
    J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
    [Abstract] [Full Text] [Related]

  • 2. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC.
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal dogs.
    Miller PE, Nelson MJ, Rhaesa SL.
    Am J Vet Res; 1996 Jan; 57(1):79-82. PubMed ID: 8720243
    [Abstract] [Full Text] [Related]

  • 5. Effects of topical administration of 0.5% apraclonidine on intraocular pressure, pupil size, and heart rate in clinically normal cats.
    Miller PE, Rhaesa SL.
    Am J Vet Res; 1996 Jan; 57(1):83-6. PubMed ID: 8720244
    [Abstract] [Full Text] [Related]

  • 6. Side-effect profile of brimonidine tartrate in children.
    Al-Shahwan S, Al-Torbak AA, Turkmani S, Al-Omran M, Al-Jadaan I, Edward DP.
    Ophthalmology; 2005 Dec; 112(12):2143. PubMed ID: 16225927
    [Abstract] [Full Text] [Related]

  • 7. Reversal of intraocular pressure increases with 0.5% apraclonidine after dilated fundus examination in patients with chronic open-angle glaucoma.
    Nishimoto JH, Chang FW, Tang IH, Kolin T.
    J Am Optom Assoc; 1999 Apr; 70(4):233-9. PubMed ID: 10457699
    [Abstract] [Full Text] [Related]

  • 8. Clinical experience with apraclonidine 0.5%.
    Gross RL, Pinyero A, Orengo-Nania S.
    J Glaucoma; 1997 Oct; 6(5):298-302. PubMed ID: 9327348
    [Abstract] [Full Text] [Related]

  • 9. Lack of cross-reactive allergic response to brimonidine in patients with known apraclonidine allergy.
    Gordon RN, Liebmann JM, Greenfield DS, Lama P, Ritch R.
    Eye (Lond); 1998 Oct; 12 ( Pt 4)():697-700. PubMed ID: 9850267
    [Abstract] [Full Text] [Related]

  • 10. Effects of apraclonidine on short-term outcome of glaucoma surgery.
    Azuara-Blanco A, Araujo SV, Lu DW, Lesk MR, Katz LJ, Spaeth GL.
    J Glaucoma; 1996 Apr; 5(2):117-9. PubMed ID: 8795743
    [Abstract] [Full Text] [Related]

  • 11. Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty.
    Threlkeld AB, Assalian AA, Allingham RR, Shields MB.
    Ophthalmic Surg Lasers; 1996 Aug; 27(8):657-60. PubMed ID: 8858630
    [Abstract] [Full Text] [Related]

  • 12. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd:YAG laser posterior capsulotomy.
    Cullom RD, Schwartz LW.
    Ophthalmic Surg; 1993 Sep; 24(9):623-6. PubMed ID: 7901828
    [Abstract] [Full Text] [Related]

  • 13. Comparing brimonidine 0.2% to apraclonidine 1.0% in the prevention of intraocular pressure elevation and their pupillary effects following laser peripheral iridotomy.
    Yuen NS, Cheung P, Hui SP.
    Jpn J Ophthalmol; 2005 Sep; 49(2):89-92. PubMed ID: 15838723
    [Abstract] [Full Text] [Related]

  • 14. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children.
    Bowman RJ, Cope J, Nischal KK.
    Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960
    [Abstract] [Full Text] [Related]

  • 15. Early intraocular pressure response to laser trabeculoplasty 180 degrees without apraclonidine versus 360 degrees with apraclonidine.
    Allf BE, Shields MB.
    Ophthalmic Surg; 1991 Sep; 22(9):539-42. PubMed ID: 1682861
    [Abstract] [Full Text] [Related]

  • 16. Long-term brimonidine therapy in glaucoma patients with apraclonidine allergy.
    Shin DH, Glover BK, Cha SC, Kim YY, Kim C, Nguyen KD.
    Am J Ophthalmol; 1999 May; 127(5):511-5. PubMed ID: 10334342
    [Abstract] [Full Text] [Related]

  • 17. [Effect and side effects of apraclonidine].
    Stewart WC.
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [Abstract] [Full Text] [Related]

  • 18. Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy.
    Robin AL.
    Ophthalmology; 1993 May; 100(5):628-33. PubMed ID: 8098520
    [Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of acetazolamide and apraclonidine in the control of intraocular pressure following phacoemulsification.
    Scuderi G, Regine F, Perdicchi A, Mannino G, Recupero SM.
    Ophthalmologica; 2006 May; 220(6):356-60. PubMed ID: 17095879
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination.
    Chen PL, Hsiao CH, Chen JT, Lu DW, Chen WY.
    Am J Ophthalmol; 2006 Sep; 142(3):469-74. PubMed ID: 16935593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.